Logo

Pacific Biosciences: Michael Hunkapiller, Susan Barnes

Jun 10, 2020

Pacific Biosciences announced that CEO and President Michael Hunkapiller will retire by the end of the year. He plans to remain on the company's board. Hunkapiller served eight years as CEO and oversaw the launch of the Sequel and Sequel II instruments.

Susan Barnes, the firm's CFO and executive VP, will also retire in August after more than a decade with the company.

PacBio said it has already begun searching for their replacements.

Breaking News
The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.